Sunil Jeram Advani MD
Assistant Professor, Radiation Medicine and Applied Sciences, UCSD School of Medicine
Join to View Full Profile
3855 Health Sciences Dr 843UCSD Moores Cancer Center Dept Radiation OncologyLa Jolla, CA 92093
Phone+1 858-822-4364
Fax+1 858-822-7400
Dr. Advani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2005 - 2009
Oregon Health Science University HospitalInternship, Transitional Year, 2004 - 2005
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
OR State Medical License 2004 - Present
CA State Medical License 2009 - 2027
IL State Medical License 2008 - 2009
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- NIH/NCI R37 MERIT Award NIH/NCI
Publications & Presentations
PubMed
- Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy.Jacqueline Lesperance, Bryan S Yung, Michael M Allevato, Marcus M Cheng, Maria F Camargo
Advanced Science. 2025-10-24 - 2 citationsSpatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapies.Mahsa Mortaja, Stephen R Adams, Rana R McKay, J Silvio Gutkind, Sunil J Advani
NPJ Precision Oncology. 2025-04-04 - 1 citationsTumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment.Mahsa Mortaja, Marcus M Cheng, Alina Ali, Jacqueline Lesperance, Dina V Hingorani
Molecules. 2024-11-27
Press Mentions
LJI Scientists Receive Curebound Funding to Advance Cancer ResearchMarch 17th, 2025
Grant Support
- Spatially precise radio-chemo-immunotherapy using antibody conjugatesUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Elucidation and therapeutic exploitation of PAK mediated radioresistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2017–2025
Research History
- Post-Doctoral Research FellowMolecular Virology1999 - 2004
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
